Home > Drug Search >
  • Targets: Calpain
  •   > 
Drug Filter
Category:
chemistry (20) biology (8)
Status:
Approved (1) Phase Ⅲ (3) Phase Ⅱ (9) Phase Ⅰ (14) IND Filing (1)
Clinical Stage:
Pending (4) Active (16) Discontinued (6)
Bio-Type:
Gene therapy (1) Vaccine (1) Whole antibody (4)
Company:
Edison pharmaceuticals (1) Endo (1) Genentech (1) Hospira (1) Janssen (1) Lilly (1) Medivation (1) Nippon Shinyaku Pharma (1) Paion Pharma (1) Paladin Pharma (1) Roche (1) Simcere (1) TauRx Pharmaceuticals (2) Tohoku University (1) Samung Medical centre (1) Asan Medical Center (1) iPierian (1) C2N Diagnostics (1) Brigham and Women's Hospital (1) NitroMed (1) Axon Biochemicals (1) Aerpio Therapeutics (1) reMYND (1) Siemens Medical Solution (1) Raptor Pharmaceutical (1) Akebia Therapeutics (1) Nivalis Therapeutics (1) QR Pharma (1) Tasly Pharm (1) Harvard University (1) Catabasis (1) DiaMedica (1) Yene Pharma (1) sGC Pharma (1) Kaneq Bioscience (1) ProteoTech (1) Ionis Pharmaceuticals (1) AC Immune (2) GE Healthcare (1) Abbott (1) Abbvie (2) Bristol-Myers Squibb (1)
Indication:
Non-alcoholic steatohepatitis (1) Alzheimer's disease (AD) (18) Asthma (1) Chronic obstructive pulmonary disease (COPD) (1) Cognitive disorders (1) Cystic fibrosis (CF) (1) Dementia (2) Diabetic macular edema (1) Hypercholesterolemia (1) Hypertension (1) Parkinson's disease (PD) (1) Type 2 diabetes (2) Stroke (1) Retinal vein occlusion (1) Progressive supranuclear palsy (3) Insulin resistance (1) Mild cognitive impairment(MCI) (1) Inherited mitochondrial respiratory chain diseases (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top